Saffron for Depression: The Research, and How It Compares to SSRIs
Saffron has been compared head-to-head with Prozac in published trials, and the results surprised a lot of people. Here is what the research shows about saffron for low mood, the dose behind it, and how it stacks up against antidepressants.
What the research shows on saffron for low mood.
Multiple randomized controlled trials have found standardized saffron extract improved depressive symptoms versus placebo, and a 2024 meta-analysis found it comparable to SSRIs with fewer reported side effects.
The largest saffron trial to date, published in The Journal of Nutrition in 2025, found saffron supplementation improved depressive symptoms in adults with subclinical depression. A 2024 meta-analysis in Nutrition Reviews compared saffron directly with SSRIs and found comparable effects with fewer reported adverse effects. The ingredient driving these results is standardized saffron extract at 28 to 30mg per day, the exact Affron dose in Mood Mod. To be clear: this is research on saffron as an ingredient, and it is not a replacement for prescription care.
Saffron has been compared head-to-head with SSRIs.
In published randomized trials, standardized saffron extract performed comparably to fluoxetine and imipramine for mild to moderate depression, with differences in reported side effects.
This is the finding that put saffron on the map. Separate randomized trials pitted saffron against fluoxetine (Prozac) and against imipramine, and on standard depression rating scales the saffron groups improved comparably to the drug groups. The 2024 meta-analysis pooling SSRI comparisons reached the same broad conclusion: comparable symptom improvement, fewer reported adverse effects. SSRIs remain the right choice for many people and are sometimes medically necessary, but the fact that a standardized botanical reached comparable results in controlled trials is genuinely notable.
Important context on medication
Saffron is a dietary supplement, not a treatment for clinical depression, and Mood Mod is not intended to diagnose, treat, cure, or prevent depression or any disease. If you have been prescribed an antidepressant, do not stop or change it based on this page. Saffron acts on serotonin pathways and can theoretically add to the effect of serotonergic medications, so combining them should only happen under a doctor's supervision.
Why Affron and the 30mg dose matter.
The depression trials were run on standardized extract, not culinary saffron. Affron guarantees a consistent level of crocins and safranal in every dose, which is why it is the form used in the published research. Raw saffron threads vary batch to batch and cannot reliably hit the studied dose. Mood Mod uses 30mg of Affron, a small margin above the 28mg studied dose, plus 200mg of L-theanine and 100mg of magnesium glycinate to round out the mood formula. The full breakdown and study list is on the science page.
The bottom line
For everyday low-mood support without a prescription, saffron at the clinical 30mg dose has some of the strongest research of any natural ingredient, including head-to-head comparisons with SSRIs. That research is exactly what Mood Mod is built on.
$1.75 per serving, as low as $1.40 on subscription. Free shipping over $50.
This page summarizes published research on saffron, L-theanine, and magnesium as ingredients and is for educational purposes only. Mood Mod is a dietary supplement, not a medication, and is not intended to diagnose, treat, cure, or prevent any disease, including anxiety or depression. Saffron acts on serotonin pathways and may interact with antidepressants and other medications; if you take an SSRI or other prescription, are pregnant, or are breastfeeding, talk to your doctor before starting any new supplement. If you are experiencing persistent or severe symptoms, please consult a licensed healthcare professional. These statements have not been evaluated by the Food and Drug Administration.
